EUCTR2011-000156-42-NL进行中（未招募）1 期
Effect of the plasma substitutes Gelofusine and Hydroxyethyl Starch 130/0.4 combined with lactated ringer's solution on the coagulation system - Effect of plasma substitutes on the coagulation system
Amphia Hospital0 个研究点目标入组 60 人开始时间: 2011年1月31日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •elective coronary artery bypass grafts procedures
- •age 18-85 year
- •Hb > 8.4 mmol/l
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Acute patiënts
- •Redo operation
- •Coagulation disorder
- •Kidney failure
研究者
相似试验
已完成
4 期
Effect of the plasma substitutes Gelofusine and Hydroxyethyl Starch 130/0.4 combined with lactated ringer's solution on the coagulation systemstollingssysteem na gebruik van de hartlongmachine bij open-hart chirurgiecoagulationplasma substitutestromboelastometryNL-OMON36390Amphia Ziekenhuis60
尚未招募
Unknown
Exploratory comparative study of plasma substitutes for Cardiopulmonary Bypass priming solutiomitral regurgitation mitral stenosisJPRN-UMIN000053336CHIBA-NISHI GENERAL HOSPITA150
尚未招募
3 期
Treatment of lowering of gumsCTRI/2024/04/065151Institute of Dental Sciences
进行中（未招募）
不适用
Is glycine absorbed in critical illness and can it prevent muscle loss?Critical illnessMuscle wasting and weaknessEnteral glycine absorptionDiet and Nutrition - Other diet and nutrition disordersMusculoskeletal - Other muscular and skeletal disordersACTRN12618000409279Royal Melbourne Hospital29
进行中（未招募）
不适用
Determination of the effect of Gelofusine on the kidney uptake of a radioactive tracer molecule used for imaging of insulin producing beta-cells in the pancreasThe aim of this study is to reduce the kidney uptake during 111In-DTPA- exendin4 imaging, a promising and valuable tool for beta-cell mass imaging and quantification, which can be applied in patients with e.g. diabetes.MedDRA version: 17.1Level: HLGTClassification code 10018424Term: Glucose metabolism disorders (incl diabetes mellitus)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 17.1Level: HLTClassification code 10012602Term: Diabetes mellitus (incl subtypes)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 17.1Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 17.1Level: PTClassification code 10067584Term: Type 1 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-003006-33-NLRadboud University Medical Center